Clinical Trials Logo

Filter by:
NCT ID: NCT04114266 Recruiting - Clinical trials for Urinary Incontinence

Registry for Patients Undergoing AUS Surgery for Female SUI Due to ISD

VENUS
Start date: June 23, 2020
Phase:
Study type: Observational [Patient Registry]

Prospective collection of pre-defined parameters of AUS Surgery for Female Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency

NCT ID: NCT04111796 Recruiting - Clinical trials for Stress, Psychological

Nature-based Solutions for Work-related Stress

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

Although exposure to nature has restorative effects on human health, beneficial effects of nature-based interventions in the working environment have been underexplored. The investigators aim to conduct a randomised controlled pilot study. During workhours one group participates in a nature-based program, the other group is a control group. The investigators test stress-related parameters including cortisol levels, wellbeing and stress, and neurocognition.

NCT ID: NCT04110327 Recruiting - Clinical trials for Peripheral Arterial Disease

An All-Comers Observational Study of the MicroStentâ„¢ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease

HEAL
Start date: October 31, 2019
Phase:
Study type: Observational [Patient Registry]

Non-randomized, multicenter, combined prospective and retrospective cohort analysis consisting of a single arm treated with the MicroStentâ„¢ System.

NCT ID: NCT04109989 Recruiting - Hysterectomy Clinical Trials

Clinical Assessment - HominisTM Surgical System

Start date: November 8, 2018
Phase: N/A
Study type: Interventional

A clinical research study designed to assess the HominisTM Surgical System in gynecological procedures.

NCT ID: NCT04109131 Recruiting - CNS Metastases Clinical Trials

A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours

BrainStorm
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

Despite some encouraging data, systemic treatment of CNS metastases from solid tumors remains experimental. Better knowledge on the evolving epidemiology and biology of BM are key elements for the development of new treatment strategies and identification of promising therapeutic targets for new compounds. Further biological findings may help to better understand the heterogeneity between the primary tumor and the CNS metastases and to identify new targets for therapy thus improving patients' outcome. In this context, the Oncodistinct network and the Jules Bordet institute propose to build a multidisciplinary Brain Metastases Clinical Research Platform called BrainStorm. The BrainStorm program will focus on patients with newly diagnosed non-CNS metastatic solid tumors with high risk of developing CNS metastases and will allow building a large clinico pathological database for CNS metastases including ctDNA analyzes from CSF samples. Substudies will be proposed at each time-period with the final objective to develop innovative treatment approaches and strategies.

NCT ID: NCT04106349 Recruiting - Clinical trials for Advanced or Metastatic Renal Cell Carcinoma

Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)

REPLICA
Start date: March 3, 2020
Phase:
Study type: Observational

The purpose of this study is to describe the real-life use of Cabometyx® in monotherapy or in combination with nivolumab in Belgium in patients with advanced or metastatic Renal Cell Carcinoma (1st, 2nd and later lines of treatment)

NCT ID: NCT04102215 Recruiting - Clinical trials for Sensorineural Hearing Loss

The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure

ARCI25
Start date: September 1, 2019
Phase: N/A
Study type: Interventional

To study the efficacy of a minimally invasive direct cochlear access via the HEARO procedure.

NCT ID: NCT04094753 Recruiting - Incontinence, Urge Clinical Trials

Think Dry: Optimalisation of Diagnostic Process of Urinary Incontinence in Older People

Start date: January 1, 2014
Phase:
Study type: Observational

Urinary incontinence is an increasing medical and socio-economical problem. 44% of the elderly (>65 years) women and 28% of the elderly men suffer from unwilling urine loss. Moreover, this percentages increase with age. Incontinence is a problem with multiple physical, psychological, and financial effects. In addition incontinence has a important impact on the family and healthcare professionals surrounding the elderly. The problem of urinary incontinence is complex and multifactorial. Moreover, diagnostic guidelines are inconsistent leading to a high amount of technical interventions to diagnose and to specify the type of incontinence. Aim of this study is to create a short form of necessary technical investigations to diagnose and evaluate urinary incontinence.

NCT ID: NCT04092543 Recruiting - Stroke, Acute Clinical Trials

Validation of DRAGON Versus a Simplified DRAGON/Machine Learning

Start date: March 1, 2019
Phase:
Study type: Observational

The CT-DRAGON score can predict long-term functional outcome after acute stroke treated by thrombolysis. However, implementation in clinical practice is hampered by a lack of validation in the broad spectrum of stroke patients undergoing thrombectomy, whether or not in combination with thrombolysis or conservative treatment. Furthermore, the CT-DRAGON score considers multiple items, which are not always readily available in every setting. This study aims to investigate whether either a simplified version of the CT-DRAGON score with only three clinical items or a machine learning technique could be as powerful and more feasible.

NCT ID: NCT04090151 Recruiting - HIV Clinical Trials

The RESPOND Outcomes Study

Start date: January 1, 2017
Phase:
Study type: Observational [Patient Registry]

The RESPOND Outcomes study is a research study around use of antiretroviral and other relevant drugs and long-term clinical outcomes in patients living with HIV. Data collected in this study will be used to answer key unanswered questions regarding treatment of people living with HIV.